OMCL Omnicell, Inc.

70.62-0.68 (-0.95%)
IEX real time price: 12:30:02 PM

Quote

Previous Close
$71.30
Day Range
$69.25-$71.23
52 Week Range
$52.20-$92.59
Volume
98,863
Avg Volume
490,938
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$2.91B
Enterprise Value (EV)
$3.01B
PE Ratio
73.04
EV/EBITDA
30.18
Price/Sales
3.73
Price/Book
4.32
PEG Ratio
0.67

Financials

Revenue
$787.31M
Gross Profit
$372.33M
EBITDA
$99.64M
EPS, ttm
$0.97
Profit Margin
4.79%
Revenue/Employee
$317.46K
Next Earnings Date
7/25/2019 (7 days)
Debt to Equity
20%
Debt
$163.45M
Cash
$67.19M
Net Debt
$96.25M

Performance

Beta
1.05
200 Day Moving Avg
$74.94
50 Day Moving Avg
$82.08
52 Week Change
31.43%
YTD Change
17.98%
1 Month Change
-15.80%
3 Month Change
-0.11%
6 Month Change
5.46%
1 Year Change
31.43%
2 Year Change
105.12%
5 Year Change
232.50%

Share Count

Shares Outstanding
41.2M
Float
-
Restricted Shares
41.2M
Restricted Shares, %
100.00%

Omnicell, Inc. Company Details

Sector: Technology Services

Industry: Information Technology Services

CEO: Randall A. Lipps

Website: http://www.omnicell.com

Description: Omnicell, Inc. engages in the provision of medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions. It operates through Automation & Analytics and Medication Adherence segments. The Automation & Analytics segment designs, manufactures, and sells medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment develops, manufactures and sells solutions to assist patients in becoming and remaining adherent to their medication regimens. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Employees: 2,480